Twist Bioscience reports GLP-1R antagonist antibody as a treatment for congenital hyperinsulinismTwist Bioscience, offering synthetic DNA using its silicon platform, has published preclinical data supporting the potential use of the...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment5 days ago